The Liver Meeting 2019-HCV+ Donors in Renal Transplantation

Video Transcription

Video Summary

In this video transcript, Dr. Christine Durand discusses the use of kidneys from donors with hepatitis C virus for transplantation. She highlights the increasing prevalence of hepatitis C due to opioid abuse and overdose deaths. Dr. Durand reviews clinical trials and real-world experiences using direct-acting antiviral therapies (DAAs) for transplant recipients. She emphasizes the need to optimize strategies for utilizing these organs effectively. Different approaches, including transmit and treat versus prophylaxis, are explored, with a focus on virologic outcomes and potential complications. The possibility of shortening treatment duration and mitigating risks of infection are also discussed. Dr. Durand advocates for moving towards clinical implementation while addressing remaining questions and considering patient perspectives.

Asset Caption

Presenter: Christine Durand

Keywords

kidneys transplantation

hepatitis C virus

direct-acting antiviral therapies

transplant recipients

clinical implementation